Yi Yin

1.2k total citations
44 papers, 916 citations indexed

About

Yi Yin is a scholar working on Small Animals, Epidemiology and Immunology. According to data from OpenAlex, Yi Yin has authored 44 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Small Animals, 15 papers in Epidemiology and 13 papers in Immunology. Recurrent topics in Yi Yin's work include Brucella: diagnosis, epidemiology, treatment (16 papers), Burkholderia infections and melioidosis (9 papers) and Galectins and Cancer Biology (6 papers). Yi Yin is often cited by papers focused on Brucella: diagnosis, epidemiology, treatment (16 papers), Burkholderia infections and melioidosis (9 papers) and Galectins and Cancer Biology (6 papers). Yi Yin collaborates with scholars based in China, United States and Hong Kong. Yi Yin's co-authors include Yanfeng Gao, Yujun Song, Barbara J. Pearce, H. Robert Masure, Jingjing Yang, Chun Kwok Wong, Yongchun Pan, Lai‐Shan Tam, Yuzhen Wang and Frederick R. Bieber and has published in prestigious journals such as Nano Letters, ACS Nano and The Journal of Immunology.

In The Last Decade

Yi Yin

42 papers receiving 903 citations

Peers

Countries citing papers authored by Yi Yin

Since Specialization

Citations

This map shows the geographic impact of Yi Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Yin more than expected).

Fields of papers citing papers by Yi Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Yin. The network helps show where Yi Yin may publish in the future.

Co-authorship network of co-authors of Yi Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Yin. A scholar is included among the top collaborators of Yi Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Yin. Yi Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biological Characterization and DIVA Potential of Three Rough Brucella melitensis Vaccine Strains 2025 ·Vaccines ·Jinyue Liu, Yi Yin, (unknown), Mengsi Li, Jing Qu, Shaohui Wang, Yanqing Bao, Jingjing Qi, T. T. Wu, Mingxing Tian	0
2	Outer membrane vesicles of Porphyromonas gingivalis: recent advances in pathogenicity and associated mechanisms 2025 ·Frontiers in Microbiology ·Zixiang Wu, Long Wei, Yi Yin, B. B. Tan, Chenyu Liu, Hongqiao Li, Ge Song	6
3	Brucella rough RB51 infection activates P53-Slc7a11-Gpx4/GSH pathway to induce ferroptosis to attenuate the intracellular survival on macrophages 2024 ·Veterinary Microbiology ·Hai Hu, Guangdong Zhang, Mingxing Tian, Yi Yin, Yanqing Bao, (unknown), Chan Ding, Shengqing Yu	8
4	Association of apolipoprotein A1 levels with lumbar bone mineral density and β-CTX in osteoporotic fracture individuals: a cross-sectional investigation 2024 ·Frontiers in Medicine ·(unknown), Ke Lü, (unknown), (unknown), (unknown), Yi Yin, (unknown)	0
5	Association between serum 25-hydroxyvitamin D and fasting blood glucose in osteoporosis patients 2023 ·Scientific Reports ·(unknown), Ke Lü, Yi Yin, (unknown), (unknown), (unknown), Qin Shi, (unknown)	1
6	Characterization of Brucella abortus Mutant A19mut2, a Potential DIVA Vaccine Candidate with a Modification on Lipopolysaccharide 2023 ·Vaccines ·(unknown), (unknown), Yi Yin, (unknown), Mingxing Tian, Shengqing Yu	2
7	Oral pyroptosis nanoinhibitor for the treatment of inflammatory bowel disease 2023 ·Nano Research ·(unknown), Dongtao Zhou, Yi Yin, Zhun Li, Zhen Guo, Yongchun Pan, Yanfeng Gao, Jingjing Yang, Weiming Zhu, Yujun Song, (unknown)	2
8	Risk Factors for Worsening of Bone Loss in Patients Newly Diagnosed with Inflammatory Bowel Disease 2022 ·Gastroenterology Research and Practice ·Yi Yin, (unknown), (unknown), Song Liu, Lihua Shao, Lei Cao, Ruiqing Liu, Liangyu Huang, (unknown), Zhen Guo, Yi Li, Weiming Zhu	9
9	Mesenteric Adipose Tissue Contributes to Intestinal Fibrosis in Crohn’s Disease Through the ATX–LPA Axis 2022 ·Journal of Crohn s and Colitis ·Liangyu Huang, Wenwei Qian, Yihan Xu, Zhen Guo, Yi Yin, Feilong Guo, Weiming Zhu, Yi Li	25
10	The novel LysR-family transcriptional regulator BvtR is involved in the resistance of Brucella abortus to nitrosative stress, detergents and virulence through the genetic regulation of diverse pathways 2022 ·Veterinary Microbiology ·Mingxing Tian, Zichen Li, Jing Qu, (unknown), Yi Yin, (unknown), (unknown), Hai Hu, Shaohui Wang, Jingjing Qi, Guijun Wang, Shengqing Yu	4
11	Nanomaterial-assisted microfluidics for multiplex assays 2022 ·Microchimica Acta ·Yanping Wang, Yanfeng Gao, Yi Yin, Yongchun Pan, Yuzhen Wang, Yujun Song	25
12	A homolog of low molecular weight protein tyrosine phosphatase isolated from Brucella melitensis displays an acidic dual specific phosphatase activity, nonessential for bacterial resistance to bactericidal factors and virulence 2022 ·Comparative Immunology Microbiology and Infectious Diseases ·(unknown), Yi Yin, (unknown), Hui Jiang, Jiabo Ding, Hai Hu, (unknown), Jingjing Qi, Mingxing Tian, (unknown)	2
13	Brucella induces heme oxygenase‐1 expression to promote its infection 2021 ·Transboundary and Emerging Diseases ·Hai Hu, Mingxing Tian, Yi Yin, (unknown), (unknown), Chan Ding, Shengqing Yu	6
14	Role of mesenteric component in Crohn’s disease: A friend or foe? 2021 ·World Journal of Gastrointestinal Surgery ·Yi Yin, (unknown), Zhun Li, Yusheng Chen, Weiming Zhu	8
15	Chylomicrons-Simulating Sustained Drug Release in Mesenteric Lymphatics for the Treatment of Crohn’s-Like Colitis 2020 ·Journal of Crohn s and Colitis ·Yi Yin, Jingjing Yang, Yongchun Pan, Zhen Guo, Yanfeng Gao, Liangyu Huang, Dongtao Zhou, Yuanyuan Ge, Feilong Guo, Weiming Zhu, Yujun Song, Yi Li	19
16	Characterization of the main immunogenic proteins in Brucella infection for their application in diagnosis of brucellosis 2020 ·Comparative Immunology Microbiology and Infectious Diseases ·Mingxing Tian, (unknown), Yi Yin, (unknown), Zichen Li, Hai Hu, (unknown), Yumei Cai, Chan Ding, Shaohui Wang, Tao Li, Jingjing Qi, Shengqing Yu	17
17	Lable-free based comparative proteomic analysis of secretory proteins of rough Brucella mutants 2019 ·Journal of Proteomics ·Peng Li, Mingxing Tian, Hai Hu, Yi Yin, (unknown), Chan Ding, Shaohui Wang, Shengqing Yu	12
18	Brucella infection regulates peroxiredoxin-5 protein expression to facilitate intracellular survival by reducing the production of nitric oxide and reactive oxygen species 2019 ·Biochemical and Biophysical Research Communications ·Hai Hu, Mingxing Tian, Peng Li, Yanqing Bao, (unknown), (unknown), Yi Yin, Chan Ding, Shengqing Yu	6
19	Interleukin 4 Deficiency Reverses Development of Secondary Pseudomonas aeruginosa Pneumonia During Sepsis-Associated Immunosuppression 2014 ·The Journal of Infectious Diseases ·Zhixin Song, Jun Zhang, Xuemei Zhang, (unknown), Haozhou Wang, Ximing Xu, Wencan Xu, Yi Yin, Ju Cao	31
20	Clinical Studies of Immunomodulatory Activities of Yunzhi-Danshen in Patients with Nasopharyngeal Carcinoma 2006 ·The Journal of Alternative and Complementary Medicine ·Yi Bao, Chun Kwok Wong, Sing Fai Leung, Anthony T.�C. Chan, (unknown), Eliza Lai‐Yi Wong, Ping‐Chung Leung, Kwok‐Pui Fung, Yi Yin, Christopher Wai Kei Lam	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact